Aligos Therapeutics, Inc.ALGSNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+48.0%
Studio
Year-over-Year Change

Year-over-year net income growth rate

3Y CAGR
+48.0%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
3.2x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202581.56%
2024-49.65%
20238.71%
202225.16%
2021-18.23%
2020-107.68%
2019-275.11%
20180.00%